Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Biotech
Calliditas' cancer trial misses primary goal, hits on survival
Calliditas saw no change in tumor size but bounced back up with early evidence of an effect on progression-free and overall survival.
Nick Paul Taylor
May 7, 2024 6:39am
GlycoMimetics fails phase 3 blood cancer trial, sinking stock
May 6, 2024 8:11am
Jacobio's KRAS data tee up safety-focused lung cancer pitch
May 1, 2024 7:01am
Newron schizophrenia add-on improves positive, negative symptoms
Apr 30, 2024 9:13am
Addex's Janssen-partnered epilepsy drug fails phase 2 trial
Apr 29, 2024 8:44am
Sanofi crosses Sjögren's off $5B drug's hit list after phase 2
Apr 25, 2024 2:35am